Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab.

MLA

Schreidah, Celine M., et al. “Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter Pylori Quadruple Therapy and Vedolizumab.” The American Journal of Dermatopathology, vol. 45, no. 8, Aug. 2023, pp. 572–76. EBSCOhost, https://doi.org/10.1097/DAD.0000000000002470.

APA

Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Kwinta, B. D., Magro, C. M., & Geskin, L. J. (2023). Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. The American Journal of Dermatopathology, 45(8), 572–576. https://doi.org/10.1097/DAD.0000000000002470

Chicago

Schreidah, Celine M, Lauren M Fahmy, Brigit A Lapolla, Bradley D Kwinta, Cynthia M Magro, and Larisa J Geskin. 2023. “Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter Pylori Quadruple Therapy and Vedolizumab.” The American Journal of Dermatopathology 45 (8): 572–76. doi:10.1097/DAD.0000000000002470.